Overview
Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency is a rare genetic condition that affects the adrenal glands — small organs that sit on top of the kidneys and produce essential hormones. In this disease, the CYP11A1 gene, which provides instructions for making an enzyme called cholesterol side-chain cleavage enzyme (also known as P450scc), does not work properly. This enzyme is the first step in making steroid hormones, including cortisol (the stress hormone) and aldosterone (which helps control salt and water balance). Because the deficiency is partial rather than complete, the adrenal glands can still produce some hormones, but not enough to meet the body's needs. This distinguishes it from complete CYP11A1 deficiency, which typically causes more severe problems including disorders of sex development in affected males. Key symptoms include fatigue, weakness, low blood pressure, salt cravings, weight loss, darkening of the skin, and episodes of adrenal crisis — a life-threatening drop in cortisol during illness or stress. Because the deficiency is partial, some patients may not show symptoms until later in childhood or even adulthood, when the body's demand for cortisol increases during illness or physical stress. Treatment centers on replacing the missing hormones with daily medications such as hydrocortisone (to replace cortisol) and sometimes fludrocortisone (to replace aldosterone). With proper hormone replacement and careful management during illness, most patients can lead relatively normal lives.
Key symptoms:
Extreme tiredness and fatigueMuscle weaknessLow blood pressureDizziness or lightheadedness when standingSalt cravingsUnexplained weight lossDarkening of the skin, especially in skin folds and creasesNausea or vomitingPoor appetiteLow blood sugar episodesDehydrationFailure to thrive in infantsIrritability in young childrenAbdominal pain
Clinical phenotype terms (50)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency.
Community
No community posts yet. Be the first to share your experience with Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency.
Start the conversation →Latest news about Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency
No recent news articles for Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What is the correct daily dose of hydrocortisone for my child, and how should it be divided throughout the day?,When and how should I increase the medication dose during illness or stress (stress dosing)?,How do I use the emergency injectable hydrocortisone, and when should I use it?,Does my child also need fludrocortisone, or is cortisol replacement alone sufficient?,What signs of adrenal crisis should I watch for, and when should I go to the emergency room?,Should other family members be tested for this genetic condition?,Are there any activities or situations my child should avoid?
Common questions about Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency
What is Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency?
Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency is a rare genetic condition that affects the adrenal glands — small organs that sit on top of the kidneys and produce essential hormones. In this disease, the CYP11A1 gene, which provides instructions for making an enzyme called cholesterol side-chain cleavage enzyme (also known as P450scc), does not work properly. This enzyme is the first step in making steroid hormones, including cortisol (the stress hormone) and aldosterone (which helps control salt and water balance). Because the deficiency is partial rather than co
How is Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency inherited?
Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.